Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

NASDAQ:DCBO - Nasdaq - CA25609L1058 - Common Stock - Currency: USD

27.37  -0.68 (-2.42%)

After market: 27.28 -0.09 (-0.33%)

Fundamental Rating

6

DCBO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. DCBO has only an average score on both its financial health and profitability. DCBO is growing strongly while it is still valued neutral. This is a good combination! This makes DCBO very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
DCBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 11.66%. This is amongst the best in the industry. DCBO outperforms 88.38% of its industry peers.
DCBO has a Return On Equity of 43.94%. This is amongst the best in the industry. DCBO outperforms 95.42% of its industry peers.
DCBO has a Return On Invested Capital of 21.50%. This is amongst the best in the industry. DCBO outperforms 94.72% of its industry peers.
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROIC 21.5%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

Looking at the Profit Margin, with a value of 10.34%, DCBO is in the better half of the industry, outperforming 76.41% of the companies in the same industry.
DCBO's Operating Margin of 9.40% is fine compared to the rest of the industry. DCBO outperforms 75.35% of its industry peers.
With an excellent Gross Margin value of 80.94%, DCBO belongs to the best of the industry, outperforming 83.80% of the companies in the same industry.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
DCBO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DCBO has been reduced compared to a year ago.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 3.56. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
DCBO has a better Altman-Z score (3.56) than 62.32% of its industry peers.
DCBO has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
DCBO has a better Debt to FCF ratio (0.04) than 82.75% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that DCBO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, DCBO is in the better half of the industry, outperforming 67.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 3.56
ROIC/WACC2.18
WACC9.85%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO's Current ratio of 1.15 is on the low side compared to the rest of the industry. DCBO is outperformed by 67.25% of its industry peers.
DCBO has a Quick Ratio of 1.15. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a worse Quick ratio (1.15) than 66.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 336.36% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 16.79% in the last year.
The Revenue has been growing by 39.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
DCBO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.94% yearly.
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.51, DCBO can be considered very expensive at the moment.
72.18% of the companies in the same industry are more expensive than DCBO, based on the Price/Earnings ratio.
DCBO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.59.
With a Price/Forward Earnings ratio of 18.88, DCBO is valued on the expensive side.
DCBO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 76.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.39. DCBO is around the same levels.
Industry RankSector Rank
PE 28.51
Fwd PE 18.88
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

DCBO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 74.30% of the companies in the same industry.
74.30% of the companies in the same industry are more expensive than DCBO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 29.57
EV/EBITDA 30.45
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
DCBO's earnings are expected to grow with 21.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (6/10/2025, 8:00:01 PM)

After market: 27.28 -0.09 (-0.33%)

27.37

-0.68 (-2.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners35.68%
Inst Owner Change0.83%
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap810.97M
Analysts78.57
Price Target29.61 (8.18%)
Short Float %1.18%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.55%
Min EPS beat(2)26.05%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)25.39%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)-11.33%
EPS beat(12)10
Avg EPS beat(12)140.75%
EPS beat(16)12
Avg EPS beat(16)97.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-0.47%
PT rev (1m)-17.33%
PT rev (3m)-19.83%
EPS NQ rev (1m)-8.8%
EPS NQ rev (3m)47.96%
EPS NY rev (1m)0%
EPS NY rev (3m)15.77%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.02%
Valuation
Industry RankSector Rank
PE 28.51
Fwd PE 18.88
P/S 3.64
P/FCF 29.57
P/OCF 28.19
P/B 15.47
P/tB 22
EV/EBITDA 30.45
EPS(TTM)0.96
EY3.51%
EPS(NY)1.45
Fwd EY5.3%
FCF(TTM)0.93
FCFY3.38%
OCF(TTM)0.97
OCFY3.55%
SpS7.52
BVpS1.77
TBVpS1.24
PEG (NY)0.72
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROCE 36.68%
ROIC 21.5%
ROICexc N/A
ROICexgc N/A
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
FCFM 12.31%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0
Cap/Depr 39.83%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 118.32%
Profit Quality 119.04%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 3.56
F-Score8
WACC9.85%
ROIC/WACC2.18
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y347.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.1%
FCF growth 1Y2197.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1283.74%
OCF growth 3YN/A
OCF growth 5YN/A